Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models

Ítems similars

• A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction
  per: Roy, Saktimayee M., et al.
  Publicat: (2019)
• Correction to “A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction”
  per: Roy, Saktimayee M., et al.
  Publicat: (2020)
• Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction
  per: Watterson, D. Martin, et al.
  Publicat: (2013)
• An isoform-selective p38αMAPK inhibitor rescues early entorhinal cortex dysfunctions in a mouse model of Alzheimer’s disease
  per: Rutigliano, Grazia, et al.
  Publicat: (2018)
• Involvement of p38 MAPK in Synaptic Function and Dysfunction
  per: Falcicchia, Chiara, et al.
  Publicat: (2020)